UCSF

Tagged: Biophysics Graduate Program (BP)

Behind enemy lines

Wed Apr 18, 2018

sourav-bandyopadhyay-original.jpg

Bandyopadhyay
Image credit: 
UCSF

Sourav Bandyopadhyay, PhD, is senior author of the paper.

Chemotherapy is modern medicine’s first line of defense against cancer: chemotherapy drugs kill dividing cells by damaging DNA, preventing tumor cells from multiplying and tumors themselves from growing. To pick which chemotherapy regimens to use, oncologists rely on broad guidelines, based on the average success rates of chemotherapies. But these guidelines don’t take into account the genetic diversity of tumors, which can make some tumors drug resistant.

UCSF School of Pharmacy leads in NIH funding for 38th year

Mon Mar 12, 2018

ucsf_20180301_lei_wang_055_by_merrell.jpg

Lei Wang and Nanxi Wang
Image credit: 
Susan Merrell

Lei Wang (left), PhD, works with postdoctoral researcher Nanxi Wang, PhD.

A culture of discovery and collaboration among faculty carries potential to “completely shake up their fields of study.”

Taking a bite out of the proteome with PhaNGS

Wed Mar 7, 2018
If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

Update from the Dean – March 2018

Thu Mar 1, 2018
A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut drug discovery time; Computational approaches target dopamine receptors; Researchers expose industry manipulation of science by sugar industry; Women in science; Bioengineering devices to treat glaucoma, diabetes, kidney disease; Campus activism on DACA; A helping hand to Puerto Rico, Basic science scholarship for women in developing nations; A decade of science camp; Honors and awards; 2017 Distinguished Alumnus of the Year; 2018 Mary Anne Koda-Kimble Seed Award for Innovation; 2018 Byers Award in Basic Science; Chan Zuckerberg Biohub Investigators; New faculty; Remembering C.C. Wang; UCSF fundraising campaign; Alumni Weekend 2018.

Babbitt named a Fellow of the International Society for Computational Biology

Fri Feb 23, 2018

pbabbitt_by_elisfall-resize.png

Babbitt
Image credit: 
Elisabeth Fall

Patricia Babbitt, PhD

Patricia C. Babbitt, PhD, has been named a Fellow of the International Society for Computational Biology (ISCB), an honor that recognizes scientists who have “distinguished themselves through outstanding contributions to the fields of computational biology and bioinformatics.”

Unmasking a cellular hallmark of cancer

Mon Jan 29, 2018

rs10565_20140121_1_0083.jpg

Wells
Image credit: 
Elisabeth Fall

James Wells, PhD, lead author on paper

Scientists identify a signature of cancers caused by mutant RAS that may lead to precise therapies.

Microscopy illuminates life

Thu Jan 25, 2018

ucsf_20180117_byers_awards_2018_024.jpg

Huang at reception
Image credit: 
Susan Merrell

Bo Huang, PhD, at Byers Award Lecture reception

Even with the best of microscopes, it's still a challenge to visualize the "inner life" of the cell.

UCSF School of Pharmacy joins data-sharing partnership to speed cancer drugs

Thu Nov 2, 2017

lawrence_livermore_computer.jpg

supercomputers
Image credit: 
Lawrence Livermore National Laboratory

A supercomputer in the Lawrence Livermore National Laboratory will be used in Project ATOM, a new public-private project that aims to speed discovery of new drug therapies.

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Computer models speed UCSF scientists toward psychiatric drug discoveries

Mon Oct 23, 2017

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia. There are five types of dopamine receptors, and psychiatric drugs usually affect multiple receptors at once, often producing debilitating or even dangerous side effects.

Update from the Dean - September 2017

Wed Sep 20, 2017
Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine. Education: Preparing leaders who think critically, work across fields, and lead in rapidly changing marketplaces. PharmD curriculum for 2018 and beyond; Transforming teaching; Coursework in regulatory science and translational medicine; Interdisciplinary exposure. Patient Care: Reframing how medication needs of patients are met. Importance of health information exchange; Outcomes research; Treating patients with more precise medications. People: Supporting our agents of change—our faculty, staff, and alumni. New faculty leaders; Housing and child care; Staff support and engagement; PharmD admissions; Unconscious bias. Framework for Success: Ensuring the School has the framework needed to excel. Support for enabling technology centers; Philanthropic support; Online presence.

Pages

Make a gift
We see a time when precise therapeutics—used safely and effectively—improve the health of people everywhere.